Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Wisee who wrote (612)	5/8/1998 7:48:00 PM
From: Paul S.	Respond to of 1185

I have to agree with Wisee, FJ Abella has been a valuable asset to this thread. Keep up the good work FJ

To: Wisee who wrote (612)	5/8/1998 8:19:00 PM
From: Mr. Forthright	Respond to of 1185

Wisee I see where your are going with this. You will agree with me that we could have fun creating a thread discussing the so called independence of financial analysts. My point was more that Jay Abella is a great promoter who doesn't have the courage to reveal his true nature. I can't have respect for him. He is not an analyst. He promotes stocks on the Internet. Sure he called NRT right and Christine called Ibex wrong. Good for him and you. I disagree with you however that NRT needs more promotion. It needs less. If the science is real it doesn't need to be so heavily promoted by newsletter writers and on the Internet. By the way Canaccord and Gordon are not players in the biotech sector. On the other hand Goepel recently hired a good biotech analyst. Maybe that will help Nortran. What do you think of the insider information being published on this thread. I think it could hurt the company. Scandals and investigations are not a good thing.